— received at the warehouses of Servicios Aeroportuarios Andinos the first batch of monkeypox vaccine doses that arrived in Peru.
These are 5,600 bottles of the Jynneos vaccine from Danish laboratory Bavarian Nordic.
The second delivery of 4,200 bottles is scheduled for November 16 so as to complete the 9,800 bottles that Peru has acquired.
"Two doses are necessary for protection against monkeypox. The second (dose) will be administered 28 days after the first dose has been applied," he specified.
The official explained that this vaccination process is not massive, but for vulnerable people at high risk of developing the disease in a severe manner.
He commented that vaccination will start in Lima, Callao, La Libertad, and Arequipa regions, where most cases have been identified.
"This vaccination will not unfold as was done to fight COVID-19 or other diseases. Therefore, during this first stage, it will be aimed at vulnerable people such as those living with HIV," Holguin specified.
Similarly, Holguin pointed out that the use of this vaccine is not authorized on minors (under 18 years of age). He indicated that young adults make up the most affected population.